Prevalence of antibody to Japanese encephalitis virus nonstructural 1 protein among racehorses in Japan: Indication of natural infection and need for continuous vaccination

Vaccine

Volumn 22, Issue 9-10, 2004, Pages 1097-1103

  Konishi, Eiji ^a   Shoda, Mizue ^a   Kondo, Takashi ^b  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EQUINE RESEARCH INSTITUTE   (Japan)

Author keywords

Horse; Japanese encephalitis; Natural infection; Vaccination

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; EPIDEMIC ENCEPHALITIS; EPIZOOTIOLOGY; FEMALE; HORSE; IMMUNOHISTOCHEMISTRY; JAPANESE ENCEPHALITIS VIRUS; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; COLORING AGENTS; ENCEPHALITIS VIRUSES, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HORSE DISEASES; HORSES; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; JAPAN; JAPANESE ENCEPHALITIS VACCINES; MALE; VACCINATION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 1542301055     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.10.001     Document Type: Article

References (20)

1. Shope RE. Medical significance of togaviruses: an overview of diseases caused by togaviruses in man and in domestic and wild vertebrate animals. In: Schlesinger RW, editor. The togaviruses. New York: Academic Press; 1980. p. 47-82.
2. Burke DS, Monath TP, Flavivirus. In: Knipe DM, Howley PM, editors. Fields virology. 4th ed. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 1043-125.
3. Hoshi S., Ito T. Statistics of equine encephalitis in Japan. Exp. Rep. Gov. Exp. Stat. Anim. Hyg. 23:1951;1-42. [in Japanese with English summary].
4. Nakamura H. Japanese encephalitis in horses in Japan. Equine Vet. J. 4:1972;155-156.
5. Kitano T, Oya A. Japanese encephalitis vaccine. In: Researcher's Associates National Institute of Health, editor. Vaccine handbook. Tokyo: Maruzen; 1996. p. 103-13.
6. Tsai TF, Yu YX. Japanese encephalitis vaccines. In: Plotkin SA, Mortimer Jr EA, editors. Vaccines. 2nd ed. Philadelphia: Saunders; 1994. p. 671-713.
7. Igarashi A. Japanese encephalitis: virus, infection, and control. In: Kurstak E, editor. Control of virus diseases. 2nd ed. New York: Marcel Dekker; 1992. p. 309-42.
8. Andersen M.M., Ronne T. Side-effects with Japanese encephalitis vaccine. Lancet. 337:1991;1044.
9. Nothdurft H.D., Jelinek T., Marschang A., Maiwald H., Kapaun A., Loscher T. Adverse reactions to Japanese encephalitis vaccine in travelers. J. Infect. 32:1996;119-122.
10. Berg S.W., Mitchell B.S., Hanson R.K.et al. Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine. Clin. Infect. Dis. 24:1997;265-266.
11. Konishi E., Suzuki T. Ratios of subclinical to clinical Japanese encephalitis (JE) virus infections in vaccinated populations: evaluation of an inactivated JE vaccine by comparing the ratios with those in unvaccinated populations. Vaccine. 21:2002;98-107.
12. Takehara K., Mitsui T., Nakamura H., Nakamura J. Studies on Japanese encephalitis live virus vaccines. I. Development of an attenuated strain of virus by serial passage in hamster kidney cell cultures. NIBS Bull. Biol. Res. 8:1969;11-22.
13. Konishi E., Pincus S., Fonseca B.A.L., Shope R.E., Paoletti E., Mason P.W. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus. Virology. 185:1991;401-410.
14. Konishi E., Mason P.W., Shope R.E. Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis. J. Med. Virol. 48:1996;76-79.
15. Takasaki T. Japanese encephalitis. In: Tuberculosis and Infectious Diseases Control Division, Health Service Bureau, Ministry of Health Labour and Welfare, Government of Japan, Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan, editors. Annual report 2001. National epidemiological surveillance of vaccine preventable diseases. 2003. p. 75-89 [in Japanese].
16. Yamaoka M., Konishi E. Recent changes in prevalence pattern of Japanese encephalitis virus in Hyogo Prefecture, Japan, using a two-dimensional distribution of IgG and IgM class antibody levels in swine sera. J. Med. Virol. 17:1985;1-7.
17. Konno J., Endo K., Agatsuma H., Ishida N. Cyclic outbreaks of Japanese encephalitis among pigs and humans. Am. J. Epidemiol. 84:1966;292-300.
18. Oya A. Recent tendencies of Japanese encephalitis. Pediatr. Jpn. 20:1979;665-669. [in Japanese].
19. Shu P.Y., Chen L.K., Chang S.F.et al. Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination. Vaccine. 19:2001;1753-1763.
20. Takashima I., Watanabe T., Ouchi N., Hashimoto N. Ecological studies of Japanese encephalitis virus in Hokkaido: interepidemic outbreaks of swine abortion and evidence for the virus to overwinter locally. Am. J. Trop. Med. Hyg. 38:1988;420-427.